Publications

Publications

 

For each publication, click on the title for more information, including the abstract, complete citation, and access to the article. You will be redirected to the National Library of Medicine.

 

 

PubMed

2-Aminothiazoles as therapeutic leads for prion diseases.
Gallardo-Godoy A
Gever J
Fife KL
Silber BM
Prusiner SB
Renslo AR
Bioluminescence imaging of Abeta deposition in bigenic mouse models of Alzheimer's disease.
Watts JC
Giles K
Grillo SK
Lemus A
DeArmond SJ
Prusiner SB
Prions.
Colby DW
Prusiner SB
A survey of antiprion compounds reveals the prevalence of non-PrP molecular targets.
Poncet-Montange G
St Martin SJ
Bogatova OV
Prusiner SB
Shoichet BK
Ghaemmaghami S
Design and construction of diverse mammalian prion strains.
Colby DW
Giles K
Legname G
Wille H
Baskakov IV
DeArmond SJ
Prusiner SB
Natural and synthetic prion structure from X-ray fiber diffraction.
Wille H
Bian W
McDonald M
Kendall A
Colby DW
Bloch L
Ollesch J
Borovinskiy AL
Cohen FE
Prusiner SB
Stubbs G
Asymptomatic deer excrete infectious prions in faeces.
Tamgüney G
Miller MW
Wolfe LL
Sirochman TM
Glidden DV
Palmer C
Lemus A
DeArmond SJ
Prusiner SB
Strain-specified characteristics of mouse synthetic prions.
Legname G
Nguyen HO
Baskakov IV
Cohen FE
Dearmond SJ
Prusiner SB
Notch-1 activation and dendritic atrophy in prion disease.
Ishikura N
Clever JL
Bouzamondo-Bernstein E
Samayoa E
Prusiner SB
Huang EJ
DeArmond SJ
Pharmacokinetics of quinacrine in the treatment of prion disease.
Yung L
Huang Y
Lessard P
Legname G
Lin ET
Baldwin M
Prusiner SB
Ryou C
Guglielmo BJ
A gamma-secretase inhibitor and quinacrine reduce prions and prevent dendritic degeneration in murine brains.
Spilman P
Lessard P
Sattavat M
Bush C
Tousseyn T
Huang EJ
Giles K
Golde T
Das P
Fauq A
Prusiner SB
Dearmond SJ
Development of antibody fragments for immunotherapy of prion diseases.
Campana V
Zentilin L
Mirabile I
Kranjc A
Casanova P
Giacca M
Prusiner SB
Legname G
Zurzolo C